P0CI65 AF NFT

Nephrocystin-3

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiagjqg7kqs2y4ojx3u6ixcn2bm34aqm64bcwzpk7ivyr2npkjfkzy/metadata.json
IPFS of structure file: 
bafybeia7ljzs7rsk5r5uwthsbq5y7n3k2wv3372xskzcyieexrn5qvqede/AF-P0CI65-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xb4D2d9c96b0D792d0b77e7147D724cc1F801ae58
First NFT owner address (bech32): 
genesis1knfdnjttp4uj6zmhuu286ujvc8uqrtjce36hs0
Current NFT ID #268115 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
268115
Accession (UniProt):
P0CI65
Name::
Nephrocystin-3
Experimental Method:
Predicted structure
Sequence source:
DANIO RERIO

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P0CI65 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P0CI65|NPHP3_DANRE Nephrocystin-3 OS=Danio rerio OX=7955 GN=nphp3 PE=3 SV=1 MGTASSLVSPGEVIEDAYGGEGGEACEIPVEVKPKARLLRSSFRRGPRVIGASFKSTGSVELEYAAEYERLRKDYEIFRVSKNNEITSMQKKEAKLDEENKRLRAELQALQKTYQKILREKESALEAKYQAMERAATFEHDRDKVKRQFKIFRETKEKEIQDLLRAKRDLESKLQQLQAQGIQIYDPADSDSDDNHTTVTTAGTQCEYWSGGVLGSEPSMGSMMQLQQTHRGPEFAHSLIDVEGPFANVSRDDWDAAVASLLQVSPHVSQSLWSNTVRCYLIYTHETKAELQTFIQTYSLRLRRFCEGLGHFYLNVSFPEEKAAVFAAERRREMERSSVCVLLLKSSVSSCVVEDVEEAFVKTPDARPLLLYLRTADRKGEKEEVSTLSPATRDLLERVNKADRSAKLKVVDHAGSVEEGAALIFSQLERIIKQELLGLELEENGVVEEREEEDSGDVLWDLHDEQEQIEAFQQACGAAARFSFQKYVDRLNDMVAAPPPTPPLLVSGAPGSGKSLLLAKWIELQQKHSPNTLILYHFTGRPLSTSTDPVLIIKRLTVKLLQHFWSISGLSMDPSKILEEFPRWLERLSARHHGNIIIIIDSIDQIQNAERHMKWLIDPLPANVRVLVSVNVETCPQAWRLWPTLHLDPLNPREVKSVISTECVSVDIKLSKDQEKKLEKHCRSAATCNALYVSLLARLITHFSTSWTLDRTLQQCVMCQDTVSLYRLGLKVALDSLNSDQEKHIMKELLCLVCASHNGISESEVLELFPDLTFPALISMLHNLERLLIITYACGLIRFQHSQACEGVNQEFLDGDKCRGSYREKCIRFFSQQLEQDRVTWRVADELPWLLQQQEDRSKLQMSLLNLFVSQNLYKRGHFSELLAYWQFVGKDKCSMATEYFDALKEFEKTCESEQSMSRLANLYETLGRFLKDLGLLSQAVAPLQRSLEIRETALDPDHPSVAQSLHQLAGVYVHWRKFGNAEQLYKQAMEICENAYGPEHSTVARELDSLSLLYQKQNKYEQAEKLRKRSVKIRQKTARQKGHMYGFALLKRRALQLEELTLGKDSTDCAKTLNELGVLYYLQNNLDAAKLFLTRSLEMRQRVLGPDHPDCAQSLNNLAALHSERKEYESAEELYERALDIRKRALAPDHPSLAYTLKHLAMLYKRRGKLEKAVPLYELALEIREKSFGPKHPSVATALVNLAVLYCQLKQHSDALPLYERALKVYEDSLGRLHPRVGETLKNLAVLSYEEGDFEKAAELYKRAMEIKEAEPSLVCGKAPSRHSSSGDTFSMRSPALPNASR